UK’s Antitrust Authority: Actavis Inflated Prices of Hydrocortisone Generics by 12,000%

Drug Industry Daily
A A
UK’s antitrust agency has accused Actavis of breaching competition law by raising the price of generic hydrocortisone tablets for Addison’s disease by more than 12,000 percent since 2008.

To View This Article:

Login

Subscribe To Drug Industry Daily